Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference63 articles.
1. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet,2017
2. The effect of advances in lung-cancer treatment on population mortality;Howlader;N. Engl. J. Med.,2020
3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin. Cancer J. Clin.,2018
4. NCCN Guidelines - NSCLC- Version 3.2020, 2020.
5. Paclitaxel – carboplatin combination chemotherapy;Pentheroudakis;Med. Oncol.,2006
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review);International Journal of Oncology;2024-02-21
2. Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues;Journal of Drug Delivery Science and Technology;2024-02
3. Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model;Journal of Controlled Release;2023-01
4. In vitro and in vivo local tolerability of a synergistic anti‐tuberculosis drug combination intended for pulmonary delivery;Journal of Applied Toxicology;2022-08-29
5. Cisplatin and paclitaxel-loaded liposomes induced cervical cancer (HeLa) cell death with multiple copies of human papillomavirus by apoptosis and decreased their cytotoxic effect on non-tumor cells;Journal of Drug Delivery Science and Technology;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3